SQSTM1 and colorectal carcinoma: As shown in Fig. 4A–C, treatment with NAC resulted in reduced ROS levels, decreased expression of MAP1LC3B-II, and accumulation of SQSTM1/p62 in m-THPC-PDT-treated CRC cells.